Genetic polymorphisms in folate pathway enzymes, DRD4 and GSTM1 are related to temporomandibular disorder

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Aneiros Guerrero, Angel ^a   Lendinez, Ana M ^a   Palomares, Arturo R ^a   Perez Nevot, Beatriz ^b   Aguado, Lidia ^a   Mayor Olea, Alvaro ^a   Ruiz Galdon, Maximiliano ^a,b   Reyes Engel, Armando ^a  

^a UNIVERSIDAD DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ABC TRANSPORTER A1; CYSTATHIONINE BETA SYNTHASE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR D4; FOLIC ACID; GLUTATHIONE TRANSFERASE M1; METHIONINE SYNTHASE REDUCTASE; METHYLENTETRAHYDROFOLATE DEHYDROGENASE; METHYLTRANSFERASE; SERINE HYDOXYMETHYLTRANSFERASE 1; TETRAHYDROFOLIC ACID; THYMIDYLATE SYNTHASE; TRANSCOBALAMIN II; UNCLASSIFIED DRUG; DOPAMINE 4 RECEPTOR; DRD4 PROTEIN, HUMAN; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLYCINE HYDROXYMETHYLTRANSFERASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; SHMT1 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; JAW DISEASE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT; ADOLESCENT; GENETIC ASSOCIATION; GENETICS; METABOLISM; MUTATION; RISK; SEX DIFFERENCE; TEMPOROMANDIBULAR JOINT DISORDER;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENETIC ASSOCIATION STUDIES; GLUTATHIONE TRANSFERASE; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D4; RISK; SEX FACTORS; TEMPOROMANDIBULAR JOINT DISORDERS; YOUNG ADULT;

EID: 79957459664     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-75     Document Type: Article

References (44)

1. The TMJ association. , http://www.tmj.org
2. National Institute of Dental and Craniofacial Research. , http://www.nidcr.nih.gov
3. National Institute of Dental and Craniofacial Research. , http://www.nidcr.nih.gov/DataStatistics/FindDataByTopic/FacialPain
4. Wang J, Chao Y, Wan Q, Zhu Z. The possible role of estrogen in the incidence of temporomandibular disorders. Med Hypotheses 2008, 71:564-567. 10.1016/j.mehy.2008.05.011, 18597950.
5. Armijo Olivo S, Magee DJ, Parfitt M, Major P, Thie NM. The asssociation between the cervical spine, the stomatognathic system and craniofacial pain: a critical review. J Orofac Pain 2006, 20:271-287.
6. Mehra P, Wolford LM. Serum nutrient deficiencies in the patient with complex temporomandibular joint problems. Proc (Bayl Univ Med Cent) 2008, 21:243-247.
7. Mäder R, Deutsch H, Siebert GK, Gerbershagen HU, Grühn E, Behl M, Kübler W. Vitamin status of in patients with chronic cephalgia and dysfunction pain syndrome and effects of a vitamin supplementation. Int J Vitam Nutr Res 1988, 58:436-441.
8. Johanson AK, Johanson A, Unell L, Norring C, Carlsson GE. Eating disorders and sign and symptoms of temporomandibular disorders: a matched case-control study. Sweed Dent J 2010, 34:139-147.
9. Slade GD, Diatchenko L, Ohrbach R, Maixner W. Orthodontic treatment, genetic factors and risk of temporomandibular disorder. Sem Orthod 2008, 14:146-156.
10. Raphael KG, Marbach JJ, Gallagher RM, Dohrenwend BP. Myofascial TMD does not run in families. Pain 1999, 80:15-22. 10.1016/S0304-3959(98)00180-8, 10204713.
11. Heiberg A, Heloe B, Heiberg AN, Heloe LA, Magnus P, Berg K, Nance WE. Myofascial pain dysfunction (MPD) syndrome in twins. Community Dent Oral Epidemiol 1980, 8:434-6. 10.1111/j.1600-0528.1980.tb01323.x, 6942960.
12. Kim BS, Kim YK, Yun PY, Lee E, Bae J. The effects of estrogen receptor polymorphism on the prevalence of symptomatic temporomandibular disorders. J Oral Maxillofac Sur 2010, 68:2975-2979.
13. Nackley AG, Diatchenko L. Assesing potential functionality of catechol-O-methyltransferase polymorphisms associated with pain and temporomandibular joint disorders. Methods Mol Biol 2010, 617:375-393. 10.1007/978-1-60327-323-7_28, 20336436.
14. Tchivileva IE, Lim PF, Smith SB, Slade GD, Diatchenko L, McLean SA, Maixner W. Effect of cathecol-O-methyltranferase polymorphism on response to propanolol therapy in chronic musculoskeletal pain: a randomized, doubled-blind, placebo-controlled, crossover pilot study. Pharmacogenet Genomics 2010, 20:239-248. 2876724, 20216107.
15. Ribeiro-Dasilva MC, Peres Line SR, Leme Godoy dos Santos MC, Arthuri MT, Hou W, Fillingim RB, Rizzatti Barbosa CM. Estrogen receptor-alpha polymorphism and predisposition to TNJ disorder. J Pain 2009, 10:527-533. 10.1016/j.jpain.2008.11.012, 2749669, 19411060.
16. Etoz OA, Ataoglu H, Erdal ME. Association between tryptophan hidroxylase gen polymorphism and painful non-osseus temporomandibular disorder. Saudi Med J 2008, 29:1352-1354.
17. Kang SC, Lee DG, Choi JH, Kim ST, Kim YK, Ahn AH. Association between estrogen receptor polymorphism and pain susceptibility in female temporomandibular joint osteoarthritis patients. Int J Oral Maxillofac Surg 2007, 36:391-394. 10.1016/j.ijom.2006.12.004, 17391927.
18. Ojima K, Narita N, Narita M. Temporomandibular disorder is associated with serotonin transporter gene polymorphism in the Japanese population. Biopsichosoc Med 2007, 1:3.
19. Lee DG, Kim TW, Kang SC, Kim ST. Estrogen receptor gene polymorphism and craniofacial morphology in female TMJ osteoarthritis patients. Int J Oral Maxillofac Surg 2006, 35:165-169. 10.1016/j.ijom.2005.06.009, 16154319.
20. Mutlu N, Erdal ME, Herken H, Oz G, Bayazit YA. T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. Oral Dis 2004, 10:349-352. 10.1111/j.1601-0825.2004.01037.x, 15533210.
21. Herken H, Erdal E, Mutlu N, Barlas O, Cataloluk O, Oz F, Güray E. Possible association of temporomandibular joint pain and dysfunction with a polymorphism in the serotonin transporter gene. Am J Orthod Dentofacial Orthop 2001, 120:308-313. 10.1067/mod.2001.115307, 11552131.
22. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66:2621-2624.
23. Landi N, Manfredini D, Lombardi I, Casarosa E, Bosco M. 17-Beta-estradiol and progesterone serum levels in temporomandibular disorder patients. Minerva Stomatol 2004, 53:651-60.
24. Halpern LR, Levine M, Dodson TB. Sexual dimorphism and temporomandibular disorders (TMD). Oral Maxillofac Surg Clin North Am 2007, 19:267-77. 10.1016/j.coms.2007.01.012, 18088884.
25. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissue Organ 2001, 169:187-192.
26. Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, Belmaker RH, Ebstein RP. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Mol Psychiatry 2000, 5:96-100. 10.1038/sj.mp.4000640, 10673775.
27. Treister R, Pud D, Ebstein RP, Laiba E, Gershon E, Haddad M, Eisenberg E. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans. Pain 2009, 147:187-93. 10.1016/j.pain.2009.09.001, 19796878.
28. McNeill C, Mohl N, Rugh J, Tanaka T. Temporomandibular disorders: diagnosis management, education, and research. J Am Dent Assoc 1990, 120:253-254.
29. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992, 6:301-55.
30. Martínez G, Shaw EM, Carrillo M, Zanuy S. A protein salting-out method applied in genomic DNA isolation from fish whole blood. Biotechniques 1998, 24:238-239.
31. Caravalho CM, Pena SD. Optimization of a multiplex minisequencing protocol for population studies and medical genetics. Genet Mol Res 2005, 4:115-125.
32. Wang L, Lu J, An J, Shi Q, Spitz MR, Wei Q. Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer 2007, 57:143-51. 10.1016/j.lungcan.2007.03.002, 2693017, 17420066.
33. De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, Capra V. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G/A polymorphism for neural tube defect risk. J Hum Genet 2006, 51:98-103. 10.1007/s10038-005-0329-6, 16315005.
34. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, Deakin M. The human glutathione S-transferases: a case-control study of the incidence of the ST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 1991, 12:25-28. 10.1093/carcin/12.1.25, 1988177.
35. Dhillon VS, Shahid M, Husain SA. Associations of MTHFR DNMT3b 4977 bp deletion in mtDNA and GSTM1 deletion, and aberrant CpG island hypermethylation of GSTM1 in non-obstructive infertility in Indian men. Mol Hum Reprod 2007, 13:213-222. 10.1093/molehr/gal118, 17277043.
36. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002, 41:13378-13385. 10.1021/bi020536s, 12416982.
37. De Luca A, Rizzardi M, Buccino A, Alessandroni R, Salvioli GP, Filograsso N, Novelli G, Dallapiccola B. Association of dopamine D4 receptor (DRD4) exon III repeat polymorphism with temperament in 3-year-old infants. Neurogenetics 2003, 4:207-212. 10.1007/s10048-003-0146-z, 12687422.
38. Wright AR, Gatchel RJ, Wildenstein L, Riggs R, Buschang P, Ellis E. Biopsychosocial differences between high-risk and low-risk patients with acute TMD-related pain. J Am Dent Assoc 2004, 135:474-483.
39. Herbig K, Chiang EP, Lee LR, Hills J, Shane B, Stover PJ. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J Biol Chem 2002, 277:38381-38389. 10.1074/jbc.M205000200, 12161434.
40. Yamaza T, Masuda KF, Atsuta I, Nishijima K, Kido MA, Tanaka T. Oxidative stress-induced DNA damage in the synovial cells of the temporomandibular joint in the rat. J Dent Res 2004, 83:619-624. 10.1177/154405910408300807, 15271970.
41. Sheets DW, Okamoto T, Dijkgraaf LC, Milam SB, Schmitz JP, Zardeneta G. Free radical damage in facsimile synovium: correlation with adhesion formation in osteoarthritic TMJs. J Prosthodont 2006, 15:9-19. 10.1111/j.1532-849X.2006.00063.x, 16433646.
42. Lee MC, Kawai Y, Shoji H, Yoshino F, Miyazaki H, Kato H, Suga M, Kubota E. Evidence of reactive oxygen species generation in synovial fluid from patient with temporomandibular disease by electron spin resonance spectroscopy. Redox Rep 2004, 9:331-336. 10.1179/135100004225006830, 15720828.
43. Tomida M, Ishimaru JI, Murayama K, Kajimoto T, Kurachi M, Era S, Shibata T. Intra-articular oxidative state correlated with the pathogenesis of disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 2004, 42:405-409. 10.1016/j.bjoms.2004.06.003, 15336765.
44. Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: a proposed hypothesis. J Oral Maxillofac Surg 1998, 56:214-23. 10.1016/S0278-2391(98)90872-2, 9461148.